Search Results
Results found for "Jan Voss"
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
dysregulated membrane trafficking, stability and phototransduction processes that lead to progressive loss
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
efficacy depends on which cells express the receptor Side effects are tied to where agonists bind Weight-loss
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic diabetes insipidus "Loss-of-function
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
Nonetheless, we determined that mGlu5a internalization was not altered upon the loss of cPKCs or nPKCs
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
To test if this loss of PM localization could contribute to the mechanism of inhibition of αqQ209L by
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
The takeaway is clear: fast clearance does not necessarily mean loss of efficacy  when binding offset
- GPR3 expression in retinal ganglion cells contributes to neuron survival and accelerates axonal...
The axonal degeneration that occurs before retinal ganglion neuronal loss is suggested to be involved
- Molecular creativity in drug discovery
Breakthroughs this week:  Orphan receptor GPRC5B in neurogenesis; Septerna’s pill-based weight-loss strategy
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
DR curves shift to the right with no loss of maximal effect.
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
discoveries could revolutionise women’s health Seven unanswered questions about blockbuster weight-loss
- Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...
oriental fruit moth Grapholita molesta is a cosmopolitan pest of orchard, which causes serious economic losses
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Build theories, but be ready to toss them.
- đź“° GPCR Weekly News, October 2 to 8, 2023
novel fluorescent Endothelin-B receptor probes GPCRs in Cardiology, Endocrinology, and Taste GPRASP1 loss-of-function
- GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth
coupling — and whether the molecular glue framing offers a productive framework for targeting gain- and loss-of-function
- GPCR Internalization: When the Signal Moves Inside the Cell
Loss of cell-surface signal from tagged receptors provides a quantitative, non-imaging measure of internalization
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
was significantly diminished iin Gαi KO and Gα_all KO HEK293 cells, however there was only a minor loss HEK293 cells with CRISPR KO of both β-arrestin1 and β-arrestin2 only led to a small but measurable loss
- đź“° GPCR Weekly News, October 9 to 15, 2023
analysis Reviews, GPCRs, and more Parallel evolution of the G protein-coupled receptor GrlG and the loss
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
loop 2 in the β2-adrenergic receptor mediates interactions with G protein and β-arrestin with a biased loss
- GPCR Selectivity Beyond the Receptor
profiles, and whether the molecular glue framing offers a productive framework for targeting gain- and loss-of-function
- đź“° GPCR Weekly News, October 23 to 29, 2023
Heptares to Host R&D Day Highlighting its Innovative R&D and Late-Stage Development Progress Parker Moss
- đź“° GPCR Weekly News, April 1 to 7, 2024
dive into the Classified GPCR News from April 1st to 7th, 2024 GPCR Activation and Signaling GPRASP1 loss-of-function
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Months of wasted resources, failed translation, and opportunity loss.
- đź“° GPCR Weekly News, June 19 to 25, 2023
Industry News Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim
- đź“° GPCR Weekly News, June 5 to 11, 2023
Ines Liebscher, Ross Cheloha and Silvio Gutkind.
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Postdoc in GPCR mechanosensing  Postdoctoral Position Postdoctoral research position Adhesion GPCRs Loss
- Drug Discovery Pharmacology Principles That Turn Assays Into Real Medicines
quote attributed to Winston Churchill: Success is the ability to go from failure to failure without loss
- The Hidden Cost of Ambition in Biotech Leadership
But loss of disciplined prioritization .
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
Rodriguez, P.J., et al., Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
- đź“° GPCR Weekly News, March 20 to 26, 2023
Loss of biased signaling at a G protein-coupled receptor in overexpressed systems.
- Unlocking the Future of Medicine: Advancements in GPCR Research
activation RhoA-mediated G12-G13 signaling maintains muscle stem cell quiescence and prevents stem cell loss














